Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Recent studies prove the ancient practice of nasal irrigation is effective at fighting the common cold - 2Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
- 3The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- 4ACA subsidies latest: Making sense of what's happening with health care after Republicans revolt, forcing a vote on funding extension
- 5Share your pick for the miniature headphones that you generally suggest!
- CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth
- The 10 Most Noteworthy Games in History
- The most effective method to Guarantee Simple Availability in Seniors' SUVs
- Ocean side Objections: Staggering Waterfront Breaks
- The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- Must-Have Cooking Machine in Your Kitchen
- A top Marine shares his secrets to keeping fit at 50
- Evaluated Smartwatches for Wellness Devotees
